Connection

JANICE NICOLE CORMIER to Cohort Studies

This is a "connection" page, showing publications JANICE NICOLE CORMIER has written about Cohort Studies.
Connection Strength

0.508
  1. The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients. J Surg Oncol. 2015 Dec; 112(8):834-40.
    View in: PubMed
    Score: 0.053
  2. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013 Apr 15; 119(8):1593-601.
    View in: PubMed
    Score: 0.043
  3. Reducing patient burden to the FACT-Melanoma quality-of-life questionnaire. Melanoma Res. 2012 Apr; 22(2):158-63.
    View in: PubMed
    Score: 0.041
  4. Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology. 2009 Dec; 42(4):161-75.
    View in: PubMed
    Score: 0.035
  5. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol. 2009 Oct; 16(10):2752-8.
    View in: PubMed
    Score: 0.034
  6. Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. Cancer. 2008 May 15; 112(10):2249-57.
    View in: PubMed
    Score: 0.032
  7. Angiosarcoma of the breast. Cancer. 2005 Dec 15; 104(12):2682-8.
    View in: PubMed
    Score: 0.027
  8. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol. 2005 Sep 01; 23(25):6054-62.
    View in: PubMed
    Score: 0.026
  9. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol. 2004 Nov 15; 22(22):4567-74.
    View in: PubMed
    Score: 0.025
  10. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol. 2020 05 01; 38(13):1429-1441.
    View in: PubMed
    Score: 0.018
  11. Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression. J Invest Dermatol. 2019 11; 139(11):2352-2358.e3.
    View in: PubMed
    Score: 0.017
  12. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913.
    View in: PubMed
    Score: 0.016
  13. Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching. Gastric Cancer. 2018 11; 21(6):1004-1013.
    View in: PubMed
    Score: 0.016
  14. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol. 2018 Apr; 117(5):879-885.
    View in: PubMed
    Score: 0.016
  15. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough? Ann Surg. 2015 Aug; 262(2):312-20.
    View in: PubMed
    Score: 0.013
  16. Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancer. Pharmacoeconomics. 2014 Oct; 32(10):1005-13.
    View in: PubMed
    Score: 0.012
  17. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.012
  18. Factors Associated with Reported Infection and Lymphedema Symptoms among Individuals with Extremity Lymphedema. Rehabil Nurs. 2015 Sep-Oct; 40(5):310-9.
    View in: PubMed
    Score: 0.012
  19. Development and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection. Ann Surg. 2012 Jan; 255(1):134-9.
    View in: PubMed
    Score: 0.010
  20. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. J Clin Oncol. 2011 Dec 10; 29(35):4654-61.
    View in: PubMed
    Score: 0.010
  21. Racial disparities in length of stay in hospice care by tumor stage in a large elderly cohort with non-small cell lung cancer. Palliat Med. 2012 Jan; 26(1):61-71.
    View in: PubMed
    Score: 0.010
  22. Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer. J Thorac Oncol. 2010 Jan; 5(1):90-8.
    View in: PubMed
    Score: 0.009
  23. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009 Apr 20; 27(12):2007-14.
    View in: PubMed
    Score: 0.008
  24. Estimation of the causal effects on survival of two-stage nonrandomized treatment sequences for recurrent diseases. Biometrics. 2006 Sep; 62(3):901-9.
    View in: PubMed
    Score: 0.007
  25. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006 Mar 15; 106(6):1276-85.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.